<SEC-DOCUMENT>0001193125-21-213350-index.html : 20210713
<SEC-HEADER>0001193125-21-213350.hdr.sgml : 20210713
<ACCEPTANCE-DATETIME>20210712210828
ACCESSION NUMBER:		0001193125-21-213350
CONFORMED SUBMISSION TYPE:	SC 13G
PUBLIC DOCUMENT COUNT:		1
FILED AS OF DATE:		20210713
DATE AS OF CHANGE:		20210712
GROUP MEMBERS:		FRANK M. SANDS
GROUP MEMBERS:		SANDS CAPITAL GLOBAL VENTURE FUND II, L.P.
GROUP MEMBERS:		SANDS CAPITAL LIFE SCIENCES PULSE FUND, LLC

SUBJECT COMPANY:	

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Acumen Pharmaceuticals, Inc.
		CENTRAL INDEX KEY:			0001576885
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		IRS NUMBER:				364108129
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		SC 13G
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	005-92677
		FILM NUMBER:		211086644

	BUSINESS ADDRESS:	
		STREET 1:		4435 NORTH FIRST STREET, SUITE 360
		CITY:			LIVERMORE
		STATE:			CA
		ZIP:			94551
		BUSINESS PHONE:		925-368-8508

	MAIL ADDRESS:	
		STREET 1:		4435 NORTH FIRST STREET, SUITE 360
		CITY:			LIVERMORE
		STATE:			CA
		ZIP:			94551

FILED BY:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Sands Capital Ventures Discovery Fund III, L.P.
		CENTRAL INDEX KEY:			0001870491
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			DE

	FILING VALUES:
		FORM TYPE:		SC 13G

	BUSINESS ADDRESS:	
		STREET 1:		C/O SANDS CAPITAL VENTURES, LLC
		STREET 2:		1000 WILSON BOULEVARD, SUITE 3000
		CITY:			ARLINGTON
		STATE:			VA
		ZIP:			22209
		BUSINESS PHONE:		703-562-4000

	MAIL ADDRESS:	
		STREET 1:		C/O SANDS CAPITAL VENTURES, LLC
		STREET 2:		1000 WILSON BOULEVARD, SUITE 3000
		CITY:			ARLINGTON
		STATE:			VA
		ZIP:			22209
</SEC-HEADER>
<DOCUMENT>
<TYPE>SC 13G
<SEQUENCE>1
<FILENAME>d165446dsc13g.htm
<DESCRIPTION>SC 13G
<TEXT>
Document 1 - file: d165446dsc13g.htm

</DOCUMENT>
</SEC-DOCUMENT>